Acura Pharmaceuticals

Last updated
Acura Pharmaceuticals Inc.
Company type Public
Nasdaq:  ACUR
Industry Pharmaceutical industry
Founded1935;90 years ago (1935) [1] : 3 
HeadquartersPalatine, Illinois
ProductsPharmaceuticals
RevenueIncrease2.svg US$ .75 million (2015) [2]
Website acurapharm.com

Acura Pharmaceuticals Inc. is a pharmaceutical company focused on the development and commercialization of deterrents to medication abuse and misuse. [3] As of 2012, the company had several opioid products under development, which would use "Aversion Technology". [4] As of 2014, it was a publicly traded company, listed on NASDAQ under the symbol "ACUR".

Contents

History

In 2013, the Company settled Oxecta patent litigation with Impax Laboratories (IPXL) and Par Pharmaceutical. [5]

License agreements

The company has an agreement to license, develop and commercialize opioid analgesic products with King Pharmaceuticals. [6]

Product adoptions

In 2013, multiple retailers – including Kroger and Fruth Pharmacy – stocked Acura's product Nexafed. [7] [8]

References

  1. ↑ "ACURA PHARMACEUTICALS, INC" (PDF). EDGAR Online . Form 10-K, 1996. Acura Pharmaceuticals. March 31, 1997. Retrieved February 15, 2014.[ permanent dead link ]
  2. ↑ "Acura Pharmaceuticals Financial Statements". United States Securities and Exchange Commission.
  3. ↑ "Acura Pharmaceuticals Announces Second Quarter 2020 Financial Results". AP NEWS. 2020-08-14. Retrieved 2021-07-22.
  4. ↑ "Acura Pharmaceuticals, Inc". Google Finance . 266634. Archived from the original on 10 May 2014. Retrieved February 15, 2014.{{cite web}}: CS1 maint: bot: original URL status unknown (link)
  5. ↑ "Acura Pharmaceuticals Inc Announces Settlement of Oxecta Patent Litigation With Par Pharmaceutical and Impax Laboratories Inc". Reuters. Reuters. October 9, 2013. Archived from the original on February 15, 2014.
  6. ↑ "ACURA PHARMACEUTICALS INC (ACUR) Company Profile & Facts - Yahoo Finance".
  7. ↑ Olsavsky, Rebecca (February 4, 2014). "Kroger stocks meth-resistant drug". Herald-Star . Archived from the original on February 15, 2014. Retrieved February 15, 2014.
  8. ↑ "New Pseudoephedrine Drug Could Hop Back Over the Counter". PharmExec. 11 December 2012. Retrieved 2021-07-22.
    This page is based on this Wikipedia article
    Text is available under the CC BY-SA 4.0 license; additional terms may apply.
    Images, videos and audio are available under their respective licenses.